EUR 76.95
(0.59%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 341.22 Million EUR | -13.23% |
2022 | 393.25 Million EUR | 6.75% |
2021 | 368.38 Million EUR | 11.54% |
2020 | 330.25 Million EUR | 164.83% |
2019 | 124.7 Million EUR | -20.91% |
2018 | 157.67 Million EUR | -16.0% |
2017 | 187.72 Million EUR | -15.11% |
2016 | 221.13 Million EUR | 4.34% |
2015 | 211.93 Million EUR | 5.24% |
2014 | 201.38 Million EUR | 6.35% |
2013 | 189.37 Million EUR | -5.23% |
2012 | 199.83 Million EUR | -8.26% |
2011 | 217.81 Million EUR | -5.64% |
2010 | 230.82 Million EUR | 9.23% |
2009 | 211.31 Million EUR | 1.82% |
2008 | 207.54 Million EUR | -10.67% |
2007 | 232.32 Million EUR | 3.53% |
2006 | 224.4 Million EUR | -43.0% |
2005 | 393.72 Million EUR | 16.71% |
2004 | 337.33 Million EUR | 22.46% |
2003 | 275.47 Million EUR | 1.49% |
2002 | 271.43 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 333.89 Million EUR | -2.15% |
2024 Q3 | 333.12 Million EUR | 5.05% |
2024 Q2 | 317.1 Million EUR | -5.03% |
2023 Q4 | 341.22 Million EUR | -2.34% |
2023 Q2 | 358.69 Million EUR | -4.02% |
2023 Q1 | 373.71 Million EUR | -4.97% |
2023 FY | 341.22 Million EUR | -13.23% |
2023 Q3 | 349.41 Million EUR | -2.59% |
2022 Q2 | 390.77 Million EUR | 3.37% |
2022 Q4 | 393.25 Million EUR | 3.74% |
2022 FY | 393.25 Million EUR | 6.75% |
2022 Q1 | 378.02 Million EUR | 2.62% |
2022 Q3 | 379.09 Million EUR | -2.99% |
2021 Q4 | 368.38 Million EUR | 5.95% |
2021 FY | 368.38 Million EUR | 11.54% |
2021 Q1 | 345.1 Million EUR | 4.49% |
2021 Q2 | 342.54 Million EUR | -0.74% |
2021 Q3 | 347.69 Million EUR | 1.5% |
2020 Q2 | 352.22 Million EUR | 27.8% |
2020 Q1 | 275.61 Million EUR | 121.01% |
2020 FY | 330.25 Million EUR | 164.83% |
2020 Q4 | 330.25 Million EUR | 0.16% |
2020 Q3 | 329.73 Million EUR | -6.39% |
2019 Q4 | 124.7 Million EUR | 10.81% |
2019 Q1 | 166.1 Million EUR | 5.34% |
2019 Q2 | 129.73 Million EUR | -21.89% |
2019 Q3 | 112.53 Million EUR | -13.26% |
2019 FY | 124.7 Million EUR | -20.91% |
2018 Q4 | 157.67 Million EUR | -9.82% |
2018 FY | 157.67 Million EUR | -16.0% |
2018 Q1 | 185.64 Million EUR | -1.1% |
2018 Q2 | 190.61 Million EUR | 2.68% |
2018 Q3 | 174.85 Million EUR | -8.27% |
2017 Q4 | 187.72 Million EUR | -7.39% |
2017 FY | 187.72 Million EUR | -15.11% |
2017 Q3 | 202.71 Million EUR | -8.77% |
2017 Q2 | 222.19 Million EUR | 2.56% |
2017 Q1 | 216.64 Million EUR | -2.03% |
2016 Q1 | 217.99 Million EUR | 2.86% |
2016 Q4 | 221.13 Million EUR | 5.54% |
2016 FY | 221.13 Million EUR | 4.34% |
2016 Q2 | 220.53 Million EUR | 1.17% |
2016 Q3 | 209.52 Million EUR | -4.99% |
2015 Q2 | 223.1 Million EUR | 8.43% |
2015 Q1 | 205.77 Million EUR | 2.18% |
2015 FY | 211.93 Million EUR | 5.24% |
2015 Q3 | 245.69 Million EUR | 10.12% |
2015 Q4 | 211.93 Million EUR | -13.74% |
2014 FY | 201.38 Million EUR | 6.35% |
2014 Q4 | 201.38 Million EUR | -5.7% |
2014 Q3 | 213.55 Million EUR | -2.95% |
2014 Q2 | 220.04 Million EUR | 7.23% |
2014 Q1 | 205.2 Million EUR | 8.36% |
2013 Q2 | 207.36 Million EUR | -4.21% |
2013 FY | 189.37 Million EUR | -5.23% |
2013 Q3 | 201.86 Million EUR | -2.65% |
2013 Q4 | 189.37 Million EUR | -6.19% |
2013 Q1 | 216.48 Million EUR | 8.33% |
2012 Q2 | 230.49 Million EUR | 8.62% |
2012 Q1 | 212.2 Million EUR | -2.58% |
2012 Q3 | 218.47 Million EUR | -5.21% |
2012 FY | 199.83 Million EUR | -8.26% |
2012 Q4 | 199.83 Million EUR | -8.53% |
2011 Q4 | 217.81 Million EUR | -1.45% |
2011 FY | 217.81 Million EUR | -5.64% |
2011 Q1 | 220.88 Million EUR | -4.3% |
2011 Q2 | 227.72 Million EUR | 3.09% |
2011 Q3 | 221.02 Million EUR | -2.94% |
2010 FY | 230.82 Million EUR | 9.23% |
2010 Q1 | 215.98 Million EUR | 2.21% |
2010 Q2 | 242.72 Million EUR | 12.38% |
2010 Q3 | 238.55 Million EUR | -1.72% |
2010 Q4 | 230.82 Million EUR | -3.24% |
2009 Q4 | 211.31 Million EUR | -7.54% |
2009 FY | 211.31 Million EUR | 1.82% |
2009 Q1 | 206.15 Million EUR | -0.67% |
2009 Q3 | 228.53 Million EUR | -1.09% |
2009 Q2 | 231.05 Million EUR | 12.08% |
2008 Q4 | 207.54 Million EUR | 0.0% |
2008 FY | 207.54 Million EUR | -10.67% |
2007 FY | 232.32 Million EUR | 3.53% |
2006 FY | 224.4 Million EUR | -43.0% |
2005 FY | 393.72 Million EUR | 16.71% |
2004 FY | 337.33 Million EUR | 22.46% |
2003 FY | 275.47 Million EUR | 1.49% |
2002 FY | 271.43 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Atrys Health, S.A. | 629 Million EUR | 45.752% |
Biotechnologies Assets SA | 16.6 Million EUR | -1954.65% |
Laboratorios Farmaceuticos Rovi, S.A. | 799.88 Million EUR | 57.341% |